D. E. Shaw & Co., Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$66,000
-33.3%
20,607
-55.0%
0.00%
Q1 2021$99,000
-13.9%
45,775
-10.8%
0.00%
Q4 2020$115,000
-52.3%
51,324
-34.9%
0.00%
Q2 2020$241,000
+338.2%
78,823
+312.9%
0.00%
Q4 2019$55,000
+17.0%
19,092
+47.7%
0.00%
Q3 2019$47,000
-42.0%
12,927
-33.7%
0.00%
Q2 2019$81,000
-3.6%
19,498
+19.3%
0.00%
Q1 2019$84,000
-78.1%
16,350
-88.4%
0.00%
-100.0%
Q2 2015$384,000
-19.2%
140,753
-0.8%
0.00%0.0%
Q1 2015$475,000
+82.0%
141,870
+88.7%
0.00%
Q4 2014$261,000
-42.8%
75,182
+127.5%
0.00%
-100.0%
Q2 2014$456,00033,0450.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders